JOHNSON & JOHNSON (JNJ) revenue & profit

JOHNSON & JOHNSON (JNJ): revenue $94.2B, net income $26.8B in 2025; latest quarter +6.6% year over year. From SEC filings.

$94.2BRevenue 2025

TickerJNJ (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$94.2B

Net income 2025$26.8B

Net margin28.5%

Annual revenue growth+6%

Latest quarter (2026 Q2) · Revenue$25.3B

vs. same quarter last year+6.6%

Latest quarter · Net income$5.5B

Annual revenue & net income

Year	Revenue	Net income
2022	$80B	$17.9B
2023	$85.2B	$35.2B
2024	$88.8B	$14.1B
2025	$94.2B	$26.8B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Johnson & Johnson Services, Inc. · Public domain · Wikimedia Commons

📷 Daderot · Public domain · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.